Lol...Yes as do we all want maximum value. Our cur

Lol...Yes as do we all want maximum value. Our currently false valuation is mostly due to lack of cash flow and inability to perform effective public outreach without having a larger well known backer...such as someone to help us with launch, marketing costs, etc. Obviously, we would see better SP value with a large cap pharma, as an immediate benefit. But we will likely need to give up a higher % of royalties which would also hurt us longterm. A mid cap pharma will be able to help us just enough to allow us to better penetrate the market. Once we've done that, it will be much easier for us for forward. Plus, with a mid cap pharma, having a market cap $10 billion and under, it would be much easier for a BP to eventually buy them out and takeover with licensing if they feels the licensing partner has a strong enough portfolio, which they would with Leronlimab.

But either way, Licensing Announcement is today or tomorrow per NP. Congrats everyone on the hard work to stick through. Maybe now, we will start to see that long run up.